XML 21 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Jan. 02, 2016
Income Statement [Abstract]      
Sales, net $ 21,201,482 $ 21,664,648 $ 17,884,886
Cost of sales 10,724,177 11,274,114 10,350,281
Gross profit 10,477,305 10,390,534 7,534,605
Operating expenses:      
Sales and marketing 4,459,224 1,558,213 1,507,868
Research and development 4,007,381 2,522,768 891,601
General and administrative 17,641,889 9,214,763 7,201,231
Other 745,773 0 0
Operating expenses 26,854,267 13,295,744 9,600,700
Operating loss (16,376,962) (2,905,210) (2,066,095)
Nonoperating income (expense):      
Interest expense, net (152,784) (333,286) (566,917)
Loss on debt extinguishment 0 (313,099) 0
Nonoperating expenses (152,784) (646,385) (566,917)
Loss before income taxes (16,529,746) (3,551,595) (2,633,012)
Provision for taxes 0 0 (4,527)
Loss from continuing operations (16,529,746) (3,551,595) (2,637,539)
Income (loss) from discontinued operations (315,140) 623,410 (133,528)
Gain on sale of discontinued operations 5,467,268 0 0
Income (loss) from discontinued operations, net 5,152,128 623,410 (133,528)
Net loss $ (11,377,618) $ (2,928,185) $ (2,771,067)
Basic and diluted earnings (loss) per common share:      
Loss from continuing operations $ (0.37) $ (0.10) $ (0.07)
Earnings (loss) from discontinued operations 0.11 0.02 (0.01)
Basic and diluted loss per common share $ (0.26) $ (0.08) $ (0.08)
Basic and diluted weighted average common shares outstanding [1] 44,598,879 37,294,321 35,877,341
[1] Includes approximately 0.5 million, 0.4 million and 0.4 million nonvested restricted stock for the years 2017, 2016 and 2015, respectively, which are participating securities that feature voting and dividend rights.